Exploring Parametric and Mechanistic Differences between Expi293F<sup>TM</sup> and ExpiCHO-S<sup>TM</sup> Cells for Transient Antibody Production Optimization
Rapidly producing drug-like antibody therapeutics for lead molecule discovery and candidate optimization is typically accomplished by large-scale transient gene expression technologies (TGE) with cultivated mammalian cells. The TGE methodologies have been extensively developed over the past three de...
Main Authors: | Jing Zhou, Guoying Grace Yan, David Cluckey, Caryl Meade, Margaret Ruth, Rhady Sorm, Amy S. Tam, Sean Lim, Constantine Petridis, Laura Lin, Aaron M. D’Antona, Xiaotian Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4468/12/3/53 |
Similar Items
-
Antibody Light Chains: Key to Increased Monoclonal Antibody Yields in Expi293 Cells?
by: Siqi Gong, et al.
Published: (2022-05-01) -
Predicting Transiently Expressed Protein Yields: Comparison of Transfection Methods in CHO and HEK293
by: Ly Porosk, et al.
Published: (2022-09-01) -
The Inhibitory Effect of Kerra<sup>TM</sup>, KS<sup>TM</sup>, and Minoza<sup>TM</sup> on Human Papillomavirus Infection and Cervical Cancer
by: Kiattawee Choowongkomon, et al.
Published: (2023-12-01) -
Optimisation of the Rectisol<sup>TM</sup> Design with Packing: the Rectisol<sup>TM</sup> Demonstration Unit
by: Eve Masurel, et al.
Published: (2018-10-01) -
A versatile genomic transgenesis platform with enhanced λ integrase for human Expi293F cells
by: Asim Azhar Siddiqui, et al.
Published: (2023-06-01)